Email updates

Keep up to date with the latest news and content from Nutrition Journal and BioMed Central.

Open Access Highly Accessed Research

Efficacy of different strategies to treat anemia in children: a randomized clinical trial

Jorge L Rosado12*, Karla E González2, María del C Caamaño12, Olga P García1, Roxana Preciado1 and Mauricio Odio3

Author Affiliations

1 Facultad de Ciencias Naturales, Universidad Autónoma de Querétaro. Querétaro, México

2 CINDETEC, Querétaro México

3 Procter and Gamble, Cincinnati Ohio, USA

For all author emails, please log on.

Nutrition Journal 2010, 9:40  doi:10.1186/1475-2891-9-40

Published: 23 September 2010

Abstract

Background

Anemia continues to be a major public health problem among children in many regions of the world, and it is still not clear which strategy to treat it is most effective.

Objective

To evaluate the efficacy and children's acceptance of several recognized strategies to treat anemia.

Methods

Non-breastfed children (n = 577), 6 to 43 mo of age, were screened for the trial; 267 were anemic (hemoglobin < 11.7 g/dL), and 266 of those were randomized into 1 of 5 treatments to received daily either: an iron supplement (IS), an iron+folic acid supplement (IFS), a multiple micronutrient supplement (MMS), a micronutrient-fortified complementary food as porridge powder (FCF), or zinc+iron+ascorbic acid fortified water (FW). The iron content of each daily dose was 20, 12.5, 10, 10 and 6.7 mg respectively. Hemoglobin (Hb), ferritin, total iron, weight and height were measured at baseline and after 4 months of treatment. Morbidity, treatment acceptability and adherence were recorded during the intervention.

Results

All treatments significantly increased Hb and total iron concentration; ferritin did not change significantly. Groups MMS, IS and IFS increased Hb (g/dL) [1.50 (95%CI: 1.17, 1.83), 1.48 [(1.18, 1.78) and 1.57 (1.26, 1.88), respectively] and total iron ((μg/dL) [0.15 (0.01, 0.29), 0.19 (0.06, 0.31) and 0.12(-0.01, 0.25), respectively] significantly more than FCF [0.92 (0.64, 1.20)] but not to FW group [0.14 (0.04, 0.24)]. The prevalence of anemia was reduced to a greater extent in the MMS and IFS groups (72% and 69%, respectively) than in the FCF group (45%) (p < 0.05). There were no significant differences in anthropometry or in the number of episodes of diarrhea and respiratory infections among treatment groups. The supplements MMS and IS were less acceptable to children, than IFS, FCF and FW.

Conclusion

The three supplements IS, ISF and MMS increased Hb more than the FCF; the supplements that contained micronutrients (IFS and MMS) were more effective for reducing the prevalence of anemia. In general, fortified foods were better accepted by the study participants than supplements.

ClinicalTrial.gov Identifier

NCT00822380